India · Delayed Price · Currency is INR Global Health Earnings Call Transcripts
Fiscal Year 2026
-
Strong year-on-year growth in revenue, EBITDA, and patient volumes, with robust expansion across mature and developing hospitals. Noida hospital ramp-up is progressing, with breakeven expected in the second half of FY 2027. CapEx plans remain disciplined, supported by a solid net cash position.
-
Q3 FY 2026 delivered 19% year-on-year income growth, with strong EBITDA margins and robust expansion, especially in Noida and developing hospitals. Margin pressures stemmed from early-stage losses and higher employee costs, but outlook remains positive with ongoing network growth and tariff improvements.
-
Q2 FY 2026 saw 15% YoY revenue growth, 21% PAT growth, and strong cash flows, driven by robust performance in both mature and developing hospitals. Noida Hospital commenced operations, and major expansion projects in Guwahati and Mumbai are underway. Talent retention remains strong, with industry-wide RPOP growth moderating.
-
Q1 FY 2026 saw record income and EBITDA, with 19% revenue and 50% PAT growth year-on-year, driven by higher patient volumes and operational efficiency. Expansion continues with new hospitals in Ranchi and Noida, and a strong cash position supports future growth and acquisitions.
Fiscal Year 2025
-
Strong year-over-year growth was reported in revenue, EBITDA, and patient volumes, with robust expansion plans including new hospitals in Mumbai, Pitampura, and Guwahati. Margins remained healthy, and the company is set to add 1,000 beds in the next two years, supported by a solid cash position.
-
Q3 FY25 delivered double-digit revenue and profit growth, driven by higher patient volumes and strong performance in both mature and developing hospitals. Major expansion projects are on track, with significant bed additions and new facilities planned, while the company maintains a robust cash position and favorable cost ratios.